Deal Dispatch: Pitney Bowes Considers Strategic Alternatives, Grant Thornton Buys CBIZ, Storj Labs Bankru
Pitney Bowes (PBI) is considering strategic alternatives, including acquisitions, divestitures, partnerships, and a possible sale, as part of its long-term plan. Other deal items include Shell’s planned sale of its BG Cyprus unit to MOL for about $720 million, and acquisitions by Grant Thornton (CBIZ), Dentalcorp, and Sargento Foods. Deal terms were largely undisclosed.
How this was made

The 30-second read
Why it matters
For Pitney Bowes, the key tradable element is the initiation or confirmation of a strategic alternatives review, which can shift expectations for M&A, divestitures, and partnerships.
Market read
Pitney Bowes’ strategic alternatives review introduces takeover and asset-sale optionality, which can drive volatility even without deal terms.
What to watch
Traders may overprice optionality without knowing balance-sheet constraints, financing availability, or whether any binding process timeline exists.
Background
The piece is a Deal Dispatch roundup, with one primary company-specific item: Pitney Bowes considering strategic alternatives including a potential sale.
Ticker impact
Pitney Bowes is evaluating strategic alternatives, including a potential sale, which can materially change deal and valuation expectations.
Shares may trade on deal-rumor sensitivity, with volatility likely until the company narrows options.
The article provides a first-order corporate action catalyst (strategic alternatives, potential sale) but no deal terms, timing, or counterparties.
Market effects
Could modestly affect sentiment around business-services and logistics-adjacent M&A activity, but the article lacks deal specifics.
No clear regional transmission beyond US-listed Pitney Bowes.
Limited, except for general cross-border deal appetite signals; most other deals mentioned are not US-listed subjects here.
Counterpoint
A strategic alternatives process does not guarantee a transaction; it can end with internal restructuring or no sale, limiting upside follow-through.
Key entities
- companyPitney Bowes Inc
Evaluating strategic alternatives including acquisitions, divestitures, partnerships, and a potential sale.


